Advertisement: Wild Knight Vodka
Advertisement: HCR Hewitsons mid banner
Advertisement: SATAVIA mid banner
Advertisement: Cambridge Network mid banner
Advertisement: Excalibur Healthcare mid banner
Advertisement: S-Tech mid banner 3
Advertisement: Bar Ellison mid banner property
Advertisement: RSM mid banner
Advertisement: partnersand mid banner
ARM Innovation Hub
Mid banner advertisement: BDO
Advertisement: Simpsons Creative
Barr Ellison Solicitors – commercial property
Advertisement: EBCam mid banner
Advertisement: CJBS mid banner
Cambridgeand mid banner advertisement
Advertisement: Mogrify mid banner
Advertisement: TTP
Advertisement: Kao Data Centre mid banner
30 September, 2021 - 12:43 By Tony Quested

Eagle Genomics and Earlham Institute reveal bioinformatics power play

Cambridge’s Eagle Genomics and the Earlham Institute in Norwich have joined forces to deliver new microbiome multi-omics datasets and tools.

The alliance will enable access to novel datasets and innovation workflows through Eagle Genomics’ AI-augmented knowledge discovery platform. Applied across both academia and industry, the partnership will facilitate access to unique resources while accelerating data-driven collaboration.

As Eagle Genomics’ foundational knowledge partner, the Earlham Institute brings a wealth of expertise in genomics and bioinformatics, as well as developing and testing laboratory methods and computational biology pipelines to study microbial communities.

The Institute has already developed a number of successful tools and datasets for bioinformaticians – such as Signalink, SalmoNet, STRONG and LotuS2.

Eagle Genomics’ platform, e[datascientist]™, applies network science to multi-dimensional life sciences data – including environmental and clinical metagenomes for multi-omics analysis.

It accelerates research and development into the understanding of human-microbiome interactions to support innovation workflows, including the generation of product claims.

Anthony Finbow, CEO of Eagle Genomics, said: “Eagle Genomics’ industry-leading open platform is helping drive the digital reinvention of life sciences R & D across numerous industries, from AgBio and food through to healthcare, personal care and beauty.

“Our partnership with the Earlham Institute is a clear demonstration of our commitment to enable a radical, global shift in microbiome science-led innovation. 

“By harnessing nature – including its complex networks and associated multi-dimensional data – we can help tackle the world’s Grand Challenges while unlocking significant economic potential.”

Eagle Genomics’ partnership with the Earlham Institute will range from collaborative R & D to consultancy work and licensing, as well as deploying e[datascientist]’s hosting and networking capabilities.

It will also provide strategic insight as part of a steering group on new pipelines, and for example, could include research into:-

  • Classification and genome reconstruction in complex environments
  • Biological signalling network resources for human and model organisms
  • Global patterns of antimicrobial resistance found in microbes
  • Investigating the persistence and evolution of human associated microbes

Dr Andrew Tingey, senior director, Global Licensing and IP Strategy at Eagle Genomics, said: “At Eagle, we’re using network science and world-leading AI tools to unlock the potential for innovation from complex multi-dimensional microbiome data.

“Our new partnership with the Earlham Institute will help support the global microbiome R & D community while shaping the future of metagenomics, linking world-leading bioinformatics pipelines, tools, and datasets.”

Eagle Genomics is currently in discussions with a range of other organisations to ensure that its platform continues to evolve as the burgeoning global life sciences knowledge discovery hub.

Newsletter Subscription

Stay informed of the latest news and features